Go back to News
NEWS
GA_P advises Impact Partners on Top Doctors Series B financing round
14 of October, 2021
Gómez-Acebo & Pombo has advised Impact Partners on its investment in Top Doctors. The Series B financing round, led by Impact Partners and in which the Institut Català de Finances (ICF) also participated, amounted to €11.2 million.
Top Doctors is a startup that offers a digital tool that allows users to access more than 90,000 experts in 50 medical specialties, while providing healthcare professionals with telemedicine solutions, online presence and brand image. The company expects to close the year with a turnover of 16 million euros, 30% more than in 2020. The capital increase will allow the company to consolidate its medical platform in the countries where it already operates in Europe, Latin America and the Middle East.
The GA_P team was formed by Álvaro Mateo and Rocío García de Oteyza, partner and associate in the Corporate area.
See complete article in CincoDías
Top Doctors is a startup that offers a digital tool that allows users to access more than 90,000 experts in 50 medical specialties, while providing healthcare professionals with telemedicine solutions, online presence and brand image. The company expects to close the year with a turnover of 16 million euros, 30% more than in 2020. The capital increase will allow the company to consolidate its medical platform in the countries where it already operates in Europe, Latin America and the Middle East.
The GA_P team was formed by Álvaro Mateo and Rocío García de Oteyza, partner and associate in the Corporate area.
See complete article in CincoDías
Press contact
Director of Business Development, Marketing and Communications
Director of Business Development, Marketing and Communications
More information about
Gómez-Acebo & Pombo
¡NEW! 
PUBLICATION
13 Dec, 2024
Invalidity of franchise providing for franchisor price-setting: implications in terms of restitution
The age-old problem of whether Article 1303 or 1306 of the Civil Code applies to contracts in breach of competition law.
13 Dec, 2024 
PUBLICATION
13 Dec, 2024
Automotive and Mobility No. 25
Summary of legislative and case law developments in the automotive sector.
13 Dec, 2024
PUBLICATION
28 Nov, 2024
Automoción y Movilidad N.º 25
Resumen de novedades legislativas y jurisprudenciales relativas al sector de la Automoción.
28 Nov, 2024
PUBLICATION
26 Nov, 2024
Pharma & Healthcare No. 41
The newsletter covers the main developments in Pharma & Healthcare legislation and case law.
26 Nov, 2024
PUBLICATION
21 Nov, 2024
Farma & Salud N.º 41
Se recogen las principales novedades legislativas y jurisprudenciales en el sector de Farma & Salud.
21 Nov, 2024
PUBLICATION
18 Oct, 2021
Inside Information and Quarterly Financial Statements: CNMV Communication of 13 October 2021
The CNMV notes in this communication that, although there are no closed periods in respect of the voluntary publication by issuers of the quarterly financial report, this report may contain inside information, in which case the Market Abuse Regulation applies
18 Oct, 2021
PUBLICATION
13 Nov, 2020
Administrative liability of the members of a listed company’s audit committee for serious errors or inaccuracies in the audited annual accounts
The Supreme Court's judgment of 8 October 2020 confirms the administrative liability of Audit Committee members for the inaccuracy or lack of veracity of consolidated annual accounts that have been externally audited
13 Nov, 2020
PUBLICATION
01 Aug, 2018
Life Sciences Newsletter No. 9
OJ L 115 of 4 May 2018 publishes Commission Regulation (EU) 2018/669 of 16 April 2018 amending, for the purposes of its adaptation to technical and scientific progress, Regulation (EC) No 1272/2008 of the European Parliament and of the Council on classification, labelling and packaging of substances and mixtures. Available at: https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32018R0669&from=EN
01 Aug, 2018